Germany tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.0% during the forecast period. Germany is significant market has been one of the significant market in the European tuberculosis diagnostic and treatment market. In 2018, a total of 5,429 tuberculosis (TB) cases were notified in Germany. The number of total cases remained almost unchanged in comparison to the 2015 which was 5,828 cases and incidence of 7.1. According to the Robert Koch institute, the tuberculosis incidence in foreign nationals residing in Germany was 19 times higher than the incidence in German citizens. This difference between the two groups increased in comparison to the previous year (16.6 times higher). The largest difference was observed in young adults. Overall, Germans comprised of 30.9 % of all tuberculosis cases, whereas the remaining 69.1 % of all cases were foreign nationals. Foreign nationals affected by tuberculosis were younger than German nationals.
Get Free Sample link @ https://www.omrglobal.com/request-sample/germany-tuberculosis-diagnosis-treatment-market
The German TB-surveillance system is essential for timely identification of epidemiological trends and their interpretation in the context of factors that potentially influence the epidemiological situation. Rising case numbers in the non-German population, multidrug-resistant and extensively drug-resistant TB, and a high proportion of infectious pulmonary TB indicate that TB remains a significant public health issue in Germany, with an increasing burden among high risk groups.
A full report of Germany Tuberculosis Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/germany-tuberculosis-diagnosis-treatment-market
- Market Coverage
- Market number available for – 2019-2025
- Base year- 2019
- Forecast period- 2020-2025
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Germany Tuberculosis Diagnosis and Treatment Market by Drugs Type
- First Line Drugs
- Second Line Drugs
Germany Tuberculosis Diagnosis and Treatment Market by Diagnosis
- Laboratory Testing
- Nucleic Acid Amplification Test
- Mantoux Test
- Radiography
- Drug Susceptibility Testing
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co.
- HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline PLC
- Hain Lifescience GmbH
- Johnson & Johnson
- OTSUKA NOVEL PRODUCTS GMBH
- Pifzer, Inc.
- Qiagen GMBH
- Sandoz Inc.
The Report Covers
- Comprehensive research methodology of the Germany Tuberculosis Diagnosis and Treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Germany Tuberculosis Diagnosis and Treatment market.
- Insights about market determinants which are stimulating the Germany Tuberculosis Diagnosis and Treatment market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/germany-tuberculosis-diagnosis-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
